What is LOPJLB’s current signal on AVIR?

LOPJLB’s latest quantitative signal on Atea Pharmaceuticals, Inc. (AVIR) is SELL in a BEAR regime. Signals are updated daily.

What market regime is AVIR in?

Atea Pharmaceuticals, Inc. (AVIR) is currently classified in the BEAR HMM market regime on LOPJLB.

Where is Atea Pharmaceuticals, Inc. based / listed?

Atea Pharmaceuticals, Inc. is based in US, listed on NASDAQ.

Atea Pharmaceuticals, Inc. (AVIR)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$5.15-0.19%Close

SELLBEAR · day 7

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $412M
Beta: 0.28
P/E (TTM): -2.44

Short % float: 13.13%
Days to cover: 25.9
SI change: +3.4%

1W: +0.39%
1M: -0.58%

vs SPY 1W: -0.77%
vs SPY 1M: -3.57%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and…

Employees: 55
Headquarters: US
Founded: 2020
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 80.0M
Float: 75.0%

ateapharma.com ↗

Key executives

Jean-Pierre Sommadossi — Founder, Chairman, Chief Executive Officer & President

Janet J. Hammond — Chief Development Officer

Andrea J. Corcoran — Chief Financial Officer, Executive Vice President of Legal & Secretary

SEC filings

EDGAR · CIK 15938990 · AVIR

Analyst consensus

Hold

Bullish125.0%

Neutral250.0%

Bearish125.0%

L $7.00Avg $7.00H $7.00

Target$7.00+35.92%

Last$5.15

Key stats

Industry peers

Prediction markets

Company news